Form4insider filings, from the source

SEC Form 4 · accession 0000914190-15-000298

BIO-TECHNE Corp · TECH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
J. Fernando Bazan
Officer — Chief Technical Officer
Period of report
Aug 7, 2015
Accepted (ET)
Aug 11, 2015 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F4$108.49Aug 7, 2015A10,000A—Aug 7, 2022Common Stock10,00010,000D
Stock Options (Right to Buy)F6$108.49Aug 7, 2015A5,000A—Aug 7, 2022Common Stock5,0005,000D
Restricted Stock UnitsF5,F6—Aug 7, 2015A800A——Common Stock800800D
Stock Option (Right to Buy)F1$76.02holding————Jul 31, 2020Common Stock10,00010,000D
Stock Option (Right to Buy)F2$76.02holding————Jul 31, 2020Common Stock15,00015,000D
Stock Option (Right to Buy)F3$94.35holding————Aug 12, 2021Common Stock15,00015,000D

Explanation of responses